CRDF - Cardiff Oncology GAAP EPS of -$0.22 beats by $0.06 revenue of $0.14M beats by $0.1M
2023-11-02 16:42:20 ET
More on Cardiff Oncology
- Cardiff Oncology (CRDF) Investor Presentation - Slideshow
- Cardiff Oncology: How The Recommitment Shapes The Investment Thesis (Rating Upgrade)
- Biggest stock movers today: Cloudflare, NextEra Energy Partners, ChargePoint and more
- Cardiff Oncology up 12% on phase 2 data for pancreatic cancer candidate
- Seeking Alpha’s Quant Rating on Cardiff Oncology
For further details see:
Cardiff Oncology GAAP EPS of -$0.22 beats by $0.06, revenue of $0.14M beats by $0.1M